Medical devices, healthcare technology and the business of care
510(k) clearance · K250954

DRX-Evolution Plus X-ray System, DRX-Compass Mobile X-ray System, Lux HD 35 detector, Lux HD 43 detector

Carestream Health · Decision date Jan 20, 2026

FDA DECISIONK250954

What did the FDA decide?

FDA records K250954 as a 510(k) premarket notification, with a decision dated Jan 20, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jan 20, 2026

FDA source record

Regulatory record facts

Identifier
K250954
Regulatory pathway
510(k) premarket notification
Product code
KPR
Decision code
SESE
Decision date
Jan 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, X-Ray, Stationary.

Product code
KPR
FDA device class
2

FDA decision timeline

  1. K250954 received

    Application receipt date recorded by FDA.

  2. K250954 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KPR

Product / regulatory recordCompanyPathwayDecision dateSource
DRTECH Corporation510(k) clearanceSep 8, 2026FDA
Siemens Medical Solutions USA, Inc.510(k) clearanceAug 31, 2026FDA
GC85AK260481
Samsung Electronics Co., Ltd.510(k) clearanceAug 27, 2026FDA
DRE DuoK260482
Jpi Healthcare Co, Ltd.510(k) clearanceJun 15, 2026FDA
DK MEDICAL SYSTEMS CO., LTD.510(k) clearanceApr 10, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Carestream Health

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Rochester, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records